BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 14757560)

  • 1. B cell chronic lymphocytic leukaemia cells have reduced capacity to upregulate expression of MHC class I in response to interferon-gamma.
    Juffs H; Fowler N; Saal R; Grimmett K; Beasley S; O'Sullivan B; Frazer I; Gill D; Thomas R
    Pathology; 2004 Feb; 36(1):69-76. PubMed ID: 14757560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.
    Seliger B; Harders C; Lohmann S; Momburg F; Urlinger S; Tampé R; Huber C
    Eur J Immunol; 1998 Jan; 28(1):122-33. PubMed ID: 9485192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the MHC class I antigen presentation machinery in human embryonal carcinomas: evidence for deficiencies in TAP, LMP and MHC class I expression and their upregulation by IFN-gamma.
    Seliger B; Dunn T; Schwenzer A; Casper J; Huber C; Schmoll HJ
    Scand J Immunol; 1997 Dec; 46(6):625-32. PubMed ID: 9420627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells.
    Frisan T; Zhang QJ; Levitskaya J; Coram M; Kurilla MG; Masucci MG
    Int J Cancer; 1996 Oct; 68(2):251-8. PubMed ID: 8900437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the major histocompatibility complex class I antigen presentation machinery in normal and malignant renal cells: evidence for deficiencies associated with transformation and progression.
    Seliger B; Hohne A; Knuth A; Bernhard H; Meyer T; Tampe R; Momburg F; Huber C
    Cancer Res; 1996 Apr; 56(8):1756-60. PubMed ID: 8620489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tap-1 and Tap-2 gene therapy selectively restores conformationally dependent HLA Class I expression in type I diabetic cells.
    Wang F; Li X; Annis B; Faustman DL
    Hum Gene Ther; 1995 Aug; 6(8):1005-17. PubMed ID: 7578413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma rescues HLA class Ia cell surface expression in term villous trophoblast cells by inducing synthesis of TAP proteins.
    Rodriguez AM; Mallet V; Lenfant F; Arnaud J; Girr M; Urlinger S; Bensussan A; Le Bouteiller P
    Eur J Immunol; 1997 Jan; 27(1):45-54. PubMed ID: 9021997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting tumour cells with defects in the MHC Class I antigen processing pathway with CD8+ T cells specific for hydrophobic TAP- and Tapasin-independent peptides: the requirement for directed access into the ER.
    Aladin F; Lautscham G; Humphries E; Coulson J; Blake N
    Cancer Immunol Immunother; 2007 Aug; 56(8):1143-52. PubMed ID: 17143611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression.
    Seliger B; Höhne A; Knuth A; Bernhard H; Ehring B; Tampé R; Huber C
    Clin Cancer Res; 1996 Aug; 2(8):1427-33. PubMed ID: 9816317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAP-independent MHC class I peptide antigen presentation to alloreactive CTL is enhanced by target cell incubation at subphysiologic temperatures.
    Shi Y; Smith KD; Lutz CT
    J Immunol; 1998 May; 160(9):4305-12. PubMed ID: 9574533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.
    Korkolopoulou P; Kaklamanis L; Pezzella F; Harris AL; Gatter KC
    Br J Cancer; 1996 Jan; 73(2):148-53. PubMed ID: 8546899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining the antigen processing components TAP and Tapasin elicits enhanced tumor-free survival.
    Lou Y; Basha G; Seipp RP; Cai B; Chen SS; Moise AR; Jeffries AP; Gopaul RS; Vitalis TZ; Jefferies WA
    Clin Cancer Res; 2008 Mar; 14(5):1494-501. PubMed ID: 18316574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of immunogenicity of a human renal-cell carcinoma cell line by TAP1-gene transfer.
    Kallfelz M; Jung D; Hilmes C; Knuth A; Jaeger E; Huber C; Seliger B
    Int J Cancer; 1999 Mar; 81(1):125-33. PubMed ID: 10077163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumor effect associated with down-regulation of MHC class 1 antigen after co-transfection of GM-CSF and IFN-gamma genes in CT26 tumor cells.
    Yoon SJ; Lee JC; Kang JO; Lee SG; Heo DS
    Anticancer Res; 2001; 21(6A):4031-9. PubMed ID: 11911288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous T lymphocytes recognize the tumour-derived immunoglobulin VH-CDR3 region in patients with B-cell chronic lymphocytic leukaemia.
    Rezvany MR; Jeddi-Tehrani M; Rabbani H; Rudén U; Hammarström L; Osterborg A; Wigzell H; Mellstedt H
    Br J Haematol; 2000 Oct; 111(1):230-8. PubMed ID: 11091206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major histocompatibility complex class I-restricted alloreactive CD4+ T cells.
    Boyle LH; Goodall JC; Gaston JS
    Immunology; 2004 May; 112(1):54-63. PubMed ID: 15096184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ABCs of immunology: structure and function of TAP, the transporter associated with antigen processing.
    Abele R; Tampé R
    Physiology (Bethesda); 2004 Aug; 19():216-24. PubMed ID: 15304636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene transfer of human interferon gamma complementary DNA into a renal cell carcinoma line enhances MHC-restricted cytotoxic T lymphocyte recognition but suppresses non-MHC-restricted effector cell activity.
    Schendel DJ; Falk CS; Nössner E; Maget B; Kressenstein S; Urlinger S; Tampé R; Gansbacher B
    Gene Ther; 2000 Jun; 7(11):950-9. PubMed ID: 10849555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of expression of MHC class I molecules and TAP genes in malignant human cell lines.
    Kaczmarek M; Frydrychowicz M; Rubis B; Mizera-Nyczak E; Nieruchalska E; Sikora J; Kaczmarek E
    Folia Histochem Cytobiol; 2007; 45(3):205-14. PubMed ID: 17951169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.